期刊文献+

CMI: Highlights in last three years

CMI: Highlights in last three years
原文传递
导出
摘要 Cellular & Molecular Immunology ( CMI) is a 13-year-old 'young' journal. In 2009, we were delighted to obtain our first impact factor score of 2.765. Since then, the impact factor of CMI has increased (Figure i). Based on the 2015 Journal Citation Report released by Thomson Reuters, CMI has reached a new impact factor milestone with a score of 5.193 (5.018 without journal self-cites) and is ranked #31 out of 150 journals in the Immunology Category. In the 'Impact Factor Era,' nothing makes journal edi- tors happier than seeing this delightful breakthrough. Here, we would like to share our happiness with our contribu- tors. On behalf of the editors of CMI, Drs Xuetao Cao, Yongjun Liu, Zhigang Tian, our guest editors and the editorial board members, we express our sincere thanks to all of the authors, peer reviewers and readers. Cellular & Molecular Immunology ( CMI) is a 13-year-old 'young' journal. In 2009, we were delighted to obtain our first impact factor score of 2.765. Since then, the impact factor of CMI has increased (Figure i). Based on the 2015 Journal Citation Report released by Thomson Reuters, CMI has reached a new impact factor milestone with a score of 5.193 (5.018 without journal self-cites) and is ranked #31 out of 150 journals in the Immunology Category. In the 'Impact Factor Era,' nothing makes journal edi- tors happier than seeing this delightful breakthrough. Here, we would like to share our happiness with our contribu- tors. On behalf of the editors of CMI, Drs Xuetao Cao, Yongjun Liu, Zhigang Tian, our guest editors and the editorial board members, we express our sincere thanks to all of the authors, peer reviewers and readers.
作者 Zhi-Qing Hu
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2016年第5期709-710,共2页 中国免疫学杂志(英文版)
  • 相关文献

参考文献16

二级参考文献273

  • 1Gourab Datta,Barry J Fuller,Brian R Davidson.Molecular mechanisms of liver ischemia reperfusion injury:Insights from transgenic knockout models[J].World Journal of Gastroenterology,2013,19(11):1683-1698. 被引量:51
  • 2Getts DR, Shankar S, Chastain EM, Martin A, Getts MT, Wood K etal. Current landscape for T-celt targeting in autoimmunity and transplantation. Immunotherapy2011; 3: 853-870.
  • 3Felix N J, Suri A, Salter-Cid L, Nadler SG, Gujrathi S, Corbo Metal. Targeting lymphocyte co-stimulation: from bench to bedside. Autoimmunity2010; 43: 514-525.
  • 4Pearl JI, Lee AS, Leveson-Gower DB, Sun N, Ghosh Z, Lan F et al. Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stern Cell 2010; 8: 309- 317.
  • 5Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H etal. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stern Cell Jan. 2014; in press.
  • 6Turka LA, Wood K, Bluestone JA. Bringing transplantation tolerance into the clinic: lessons from the ITN and RISET for the Establishment of Tolerance consortia. Curr Opin Organ Transplant 2010; 15:441- 448.
  • 7Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, Shizuru JA et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362- 368.
  • 8Vodyanik MA, Bork JA, Thomson JA, Slukvin II. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005; 105: 617-626.
  • 9Ledran M H, Krassowska A, Armstrong L, Dimmick I, Renstrem J, Lang R et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 2008; 3: 85-98.
  • 10Woods NB, Parker AS, Moraghebi R, Lutz MK, Firth AL, Brennand KJ et al. Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines. Stem Cell 2011; 29: 1158-1164.

共引文献282

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部